http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2008004901-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8cdfbc70d9776e1ea4502b21128b30c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2006-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b69c2a84794f6e9f875c9779be3667 |
| publicationDate | 2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2008004901-A |
| titleOfInvention | AGENTS TO DELETE DAMAGE TO TRANSPLANTED ISLOTS AFTER THE ISLOT TRANSPLANT. |
| abstract | An anti-IL-6 receptor antibody is reviewed for its inhibitory effect against transplanted islet dysfunction produced after islet transplantation. As a result, it was discovered that the anti-IL-6 receptor antibody can reduce the transplanted islet dysfunction, improve the survival of the transplanted islet, and also improve the hyperglycemic state of a receptor. It was also discovered that the administration of the anti-IL-6 receptor antibody makes it possible to prevent the production of an inflammatory cytokine in an identification cell after transplantation. Therefore, it was discovered that transplanted islet dysfunction produced after islet transplantation can be prevented using the anti-IL-6 receptor antibody. |
| priorityDate | 2005-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 584.